Alain U. Vetterli
Chief Executive Officer at A&M Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Garry Paul McCann | M | 63 |
Pulmo BioTech, Inc.
 Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 years |
| Peter B. Hirshfield | M | 78 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Vardakis | M | 59 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 years |
| Matthew C. Lords | M | 55 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 years |
| Robert Lawrence Banner | M | 80 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 1 years |
| Ian Ilsley | M | 75 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alain U. Vetterli
- Personal Network
